BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/18/2015 5:02:00 PM | Browse: 1127 | Download: 1567
 |
Received |
|
2014-08-02 12:43 |
|
Peer-Review Started |
|
2014-08-02 20:18 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-09-09 10:14 |
|
Revised |
|
2014-09-13 17:55 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-11-19 08:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-12-01 13:36 |
|
Articles in Press |
|
2014-12-01 13:58 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-04-27 09:39 |
|
Publish the Manuscript Online |
|
2015-05-18 17:02 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Oral mixture of autologous colon-extracted proteins for the Crohn’s disease: A double-blind trial
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Eran Israeli, Ehud Zigmond, Gadi Lalazar, Athalia Klein, Nilla Hemed, Eran Goldin and Yaron Ilan |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| ENZO Biochem, New York City, NY, United States, and the Roaman-Epstein Liver Research Foundation |
to Ilan Y(in part) |
|
| Corresponding Author |
Yaron Ilan, MD, Gastroenterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center, POB 12000, IL-91120 Jerusalem, Israel. ilan@hadassah.org.il |
| Key Words |
Oral tolerance; Crohn’s disease; Natural killer T cells; Immune modulation |
| Core Tip |
Oral administration of the autologous colonic extract could be a safe and effective for the treatment of patients with moderate to severe Crohn’s disease (CD). Increased ratio of CD4+/CD8+ T lymphocytes was noted in subjects with a significant clinical response and may serve as a biomarker for response to therapy. |
| Publish Date |
2015-05-18 17:02 |
| Citation |
Israeli E, Zigmond E, Lalazar G, Klein A, Hemed N, Goldin E, Ilan Y. Oral mixture of autologous colon-extracted proteins for the Crohn’s disease: A double-blind trial. World J Gastroenterol 2015; 21(18): 5685-5694 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i18/5685.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i18.5685 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
